The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumor

Triggering receptor expressed on myeloid cell-2 (TRE M2) is a transmembrane receptor which is specifically expressed on myeloid cells. To date, TRE M2 has been confirmed as a key factor in many pathologies, such as Alzheimer’s disease, obesity-related metabolic syndrome, fatty liver and atherosclero...

Full description

Bibliographic Details
Main Authors: Yahui Wang, Ying Chu, Fenghua Cao, Zhihong Chen, Huaxi Xu, Shengjun Wang, Jie Ma
Format: Article
Language:English
Published: Termedia Publishing House 2023-01-01
Series:Central European Journal of Immunology
Subjects:
Online Access:https://www.termedia.pl/The-emerging-role-of-triggering-receptor-expressed-on-myeloid-cell-2-in-malignant-tumor,10,49990,1,1.html
_version_ 1827058468950900736
author Yahui Wang
Ying Chu
Fenghua Cao
Zhihong Chen
Huaxi Xu
Shengjun Wang
Jie Ma
author_facet Yahui Wang
Ying Chu
Fenghua Cao
Zhihong Chen
Huaxi Xu
Shengjun Wang
Jie Ma
author_sort Yahui Wang
collection DOAJ
description Triggering receptor expressed on myeloid cell-2 (TRE M2) is a transmembrane receptor which is specifically expressed on myeloid cells. To date, TRE M2 has been confirmed as a key factor in many pathologies, such as Alzheimer’s disease, obesity-related metabolic syndrome, fatty liver and atherosclerosis. However, the role of TRE M2 in tumors remains poorly understood. TRE M2 is highly expressed in more than 200 primary and metastatic tumors, a feature that makes TRE M2 a potential clinical target for tumor immunotherapy. The tumor microenvironment (TME) is the “soil” which tumors survive on and exhibits immunosuppressive characteristics. During the development of a tumor, TME will secrete various chemotactic factors to recruit myeloid cells. It is clear now that cancer progression and metastasis depend on the interactions between cancer cells and myeloid cell infiltration in TME. As an important receptor involved in inflammatory suppression signaling pathways, TRE M2 may play an important role in immune escape by the tumor. Recently, several studies have illustrated that TRE M2 expressed on tumor infiltrated myeloid cells acts as a crucial regulator of the antitumor immune response. In this review, we systematically summarize recent publications about the latest advances in knowledge of TRE M2 in cancer, especially focusing on its role in tumor associated myeloid cells and tumor immunotherapy.
first_indexed 2024-04-09T16:52:00Z
format Article
id doaj.art-1e1ddb2b37e34fb781b350a1572be788
institution Directory Open Access Journal
issn 1426-3912
1644-4124
language English
last_indexed 2025-02-18T18:24:25Z
publishDate 2023-01-01
publisher Termedia Publishing House
record_format Article
series Central European Journal of Immunology
spelling doaj.art-1e1ddb2b37e34fb781b350a1572be7882024-10-22T08:02:30ZengTermedia Publishing HouseCentral European Journal of Immunology1426-39121644-41242023-01-0147437338110.5114/ceji.2022.12438749990The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumorYahui WangYing ChuFenghua CaoZhihong ChenHuaxi XuShengjun WangJie MaTriggering receptor expressed on myeloid cell-2 (TRE M2) is a transmembrane receptor which is specifically expressed on myeloid cells. To date, TRE M2 has been confirmed as a key factor in many pathologies, such as Alzheimer’s disease, obesity-related metabolic syndrome, fatty liver and atherosclerosis. However, the role of TRE M2 in tumors remains poorly understood. TRE M2 is highly expressed in more than 200 primary and metastatic tumors, a feature that makes TRE M2 a potential clinical target for tumor immunotherapy. The tumor microenvironment (TME) is the “soil” which tumors survive on and exhibits immunosuppressive characteristics. During the development of a tumor, TME will secrete various chemotactic factors to recruit myeloid cells. It is clear now that cancer progression and metastasis depend on the interactions between cancer cells and myeloid cell infiltration in TME. As an important receptor involved in inflammatory suppression signaling pathways, TRE M2 may play an important role in immune escape by the tumor. Recently, several studies have illustrated that TRE M2 expressed on tumor infiltrated myeloid cells acts as a crucial regulator of the antitumor immune response. In this review, we systematically summarize recent publications about the latest advances in knowledge of TRE M2 in cancer, especially focusing on its role in tumor associated myeloid cells and tumor immunotherapy.https://www.termedia.pl/The-emerging-role-of-triggering-receptor-expressed-on-myeloid-cell-2-in-malignant-tumor,10,49990,1,1.htmltriggering receptor expressed on myeloid cell-2 malignant tumor tumor immunotherapy tumor infiltrating myeloid cells
spellingShingle Yahui Wang
Ying Chu
Fenghua Cao
Zhihong Chen
Huaxi Xu
Shengjun Wang
Jie Ma
The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumor
Central European Journal of Immunology
triggering receptor expressed on myeloid cell-2
malignant tumor
tumor immunotherapy
tumor infiltrating myeloid cells
title The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumor
title_full The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumor
title_fullStr The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumor
title_full_unstemmed The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumor
title_short The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumor
title_sort emerging role of triggering receptor expressed on myeloid cell 2 in malignant tumor
topic triggering receptor expressed on myeloid cell-2
malignant tumor
tumor immunotherapy
tumor infiltrating myeloid cells
url https://www.termedia.pl/The-emerging-role-of-triggering-receptor-expressed-on-myeloid-cell-2-in-malignant-tumor,10,49990,1,1.html
work_keys_str_mv AT yahuiwang theemergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor
AT yingchu theemergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor
AT fenghuacao theemergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor
AT zhihongchen theemergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor
AT huaxixu theemergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor
AT shengjunwang theemergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor
AT jiema theemergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor
AT yahuiwang emergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor
AT yingchu emergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor
AT fenghuacao emergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor
AT zhihongchen emergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor
AT huaxixu emergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor
AT shengjunwang emergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor
AT jiema emergingroleoftriggeringreceptorexpressedonmyeloidcell2inmalignanttumor